Filana Therapeutics, Inc.
FLNANasdaqCIK 1069530HealthcareFiscal year ends Dec 31
Reports and events: 307 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2012:17 ET | 8-K | 8.01 Other events | 0001437749-26-032971 |
| 2026-09-2212:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-006161 |
| 2026-09-1820:16 ET | 8-K | 3.01 Delisting notice | 0001437749-26-030751 |
| 2026-07-2912:28 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-024752 |
| 2026-07-2912:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004982 |
| 2026-06-1510:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-020562 |
| 2026-05-0721:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015664 |
| 2026-05-0712:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003119 |
| 2026-04-2820:04 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001437749-26-013654 |
| 2026-04-2820:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-013638 |
| 2026-03-1220:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-007962 |
| 2026-03-1212:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001506 |
| 2026-03-1012:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-007422 |
| 2026-02-1913:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000922 |
| 2025-12-2313:46 ET | 8-K | 1.01 Entry into a material agreement | 0001437749-25-038605 |
| 2025-12-2221:09 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-038544 |
| 2025-12-1822:02 ET | 8-K | 8.01 Other events | 0001437749-25-038313 |
| 2025-12-1721:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-038157 |
| 2025-12-0311:27 ET | 8-K | 8.01 Other events | 0001437749-25-036710 |
| 2025-11-1221:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034427 |
| 2025-11-1213:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007222 |
| 2025-10-2412:10 ET | 8-K | 8.01 Other events | 0001437749-25-031674 |
| 2025-10-2212:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-031466 |
| 2025-09-0813:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-028530 |
| 2025-08-1412:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026686 |
| 2025-08-1411:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005406 |
| 2025-08-0411:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-004981 |
| 2025-06-3011:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004211 |
| 2025-05-2720:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-018482 |
| 2025-05-0820:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015478 |
| 2025-05-0812:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002954 |
| 2025-04-2120:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-012540 |
| 2025-04-1411:46 ET | DEF 14A | Proxy statementPeriod 2025-05-23 | 0001437749-25-011848 |
| 2025-03-2512:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001678 |
| 2025-03-1119:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-007019 |
| 2025-03-0321:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-005919 |
| 2025-03-0312:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001183 |
| 2025-02-2712:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-005338 |
| 2025-01-0721:40 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-000089 |
| 2024-11-2512:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-006545 |
| 2024-11-0721:29 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-033944 |
| 2024-11-0713:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006089 |
| 2024-10-0812:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030845 |
| 2024-10-0120:07 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-030345 |
| 2024-09-2711:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-030118 |
| 2024-09-1720:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-029380 |
| 2024-09-0912:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005116 |
| 2024-08-0912:23 ET | 8-K/A | 2.02 Results of operations | 0001437749-24-025654 |
| 2024-08-0821:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025611 |
| 2024-08-0812:13 ET | 8-K | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001171843-24-004561 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.